Glenmark Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | |
|---|---|---|
| EBITDA | 2,135 | 2,487 |
| EBIT | 1,736 | 1,739 |
| Earning Per Share | 34 | 33 |
| Expenses | 8,860 | 9,985 |
| Net Profit | 970 | 994 |
| Net Profit Margin | 9 | 8 |
| Operating Profit Margin | 20 | 20 |
| Profit Before Tax | 1,382 | 1,441 |
| Dividends Per Share | 3 | 3 |
| Operation Revenue | 10,994 | 12,472 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2022 | 98.23 | 103.10 | 86.20 | 2,445.23 | 97.80 | |
| 2022 | 1,739.20 | 2,486.90 | 993.60 | 9,042.13 | 1,441.20 | |
| 2022 | -1,229.80 | 428.90 | -1,509.70 | 11,900.64 | -1,372.50 | |
| 2022 | 3,086.90 | 4,252.10 | 2,112.20 | 18,985.90 | 2,991.10 | |
| 2022 | 4,608.60 | 11,319.20 | 3,405.80 | 47,771.29 | 4,481.30 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| Operating Activities | 1,648 | 1,324 | 1,392 | 1,131 | 1,109 |
| Investing Activities | -1,013 | -699 | -784 | -675 | -333 |
| Financing Activities | -468 | -739 | -445 | -442 | -520 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 166 | -114 | 164 | 14 | 255 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2022 | -17.75 | 18.85 | -5.82 | -4.72 | |
| 2022 | 1,108.65 | -333.28 | -520.49 | 254.88 | |
| 2022 | 367.31 | 1,292.23 | -1,572.32 | 87.22 | |
| 2016 | 3,262.60 | -2,039.40 | -1,700.10 | -476.90 | |
| 2018 | 3,907.15 | -3,370.81 | -1,539.26 | -1,002.92 |
Financials
All values are in Rs Cr